Primary bone lymphoma – the University of Miami experience

References

• Oberling C. Les reticulosarcomes et les reticuloendotheliosarcomes de la moelle osseuse (sarcomes d'Ewing). Bull Assoc Fr Étude Cancer 1928;17:259–296.
   Google Scholar
• Parker F, Jackson H. Primary reticulum cell sarcoma of bone. Surg Gynecol Obstet 1939;68:45–53.
   Google Scholar
• Dahlin DC, Unni KK. Bone Tumors: General Aspects and Data on 8,542 CasesSpringfield, IL: Charles C. Thomas Publisher Limited; 1986. 538.
   Google Scholar
• Limb D, Dreghorn C, Murphy JK, et al Primary lymphoma of bone. Int Orthop 1994;18:180–183.
   PubMed Web of Science ®Google Scholar
• Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252–260.
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Diamond HD, Jaslowitz B, et al Lymphosarcoma: a review of 1269 cases. Medicine (Baltimore) 1961;40:31–84.
   PubMed Web of Science ®Google Scholar
• Dubey P, Ha CS, Besa PC, et al Localized primary malignant lymphoma of bone. Int J Radiat Oncol Biol Phys 1997;37:1087–1093.
   PubMed Web of Science ®Google Scholar
• Coley BL, Higinbotham NL, Groesbeck HP. Primary reticulum-cell sarcoma of bone; summary of 37 cases. Radiology 1950;55:641–658.
   PubMed Web of Science ®Google Scholar
• Ferreri AJ, Reni M, Ceresoli GL, et al Therapeutic management with adriamycin-containing chemotherapy and radiotherapy of monostotic and polyostotic primary non-Hodgkin's lymphoma of bone in adults. Cancer Invest 1998;16:554–561.
   PubMed Web of Science ®Google Scholar
• Shoji H, Miller TR. Primary reticulum cell sarcoma of bone. Significance of clinical features upon the prognosis. Cancer 1971;28:1234–1244.
   PubMed Web of Science ®Google Scholar
• Fletcher CDM, Unni KK, Mertens F, editors.Pathology and Genetics of Tumors of Soft Tissue and Bone: World Health Organization Classification of TumoursLyon, France: IARC Press: 2002. 427.
   Google Scholar
• Jaffe ES, Harris NL, Stein H, et al Pathology and Genetics of Tumours of Haematopoietic and Lymphoid TissuesLyon, France: IARC Press, 2001. 351.
   Google Scholar
• Ostrowski ML, Unni KK, Banks PM, et al Malignant lymphoma of bone. Cancer 1986;58:2646–2655.
   PubMed Web of Science ®Google Scholar
• Ramadan KM, Shenkier T, Sehn LH, et al A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol 2007;18:129–135.
   PubMed Web of Science ®Google Scholar
• Lewis V, Primus G, Anastasi J, et al Oncologic outcomes of primary lymphoma of bone in adults. Clin Orthop Relat Res 2003;415:90–97.
   PubMed Web of Science ®Google Scholar
• Heyning FH, Hogendoorn PC, Kramer MH, et al Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia 1999;13:2094–2098.
   PubMed Web of Science ®Google Scholar
• Mulligan ME, McRae GA, Murphey MD. Imaging features of primary lymphoma of bone. AJR Am J Roentgenol 1999;173:1691–1697.
   PubMed Web of Science ®Google Scholar
• Maruyama D, Watanabe T, Beppu Y, et al Primary bone lymphoma: a new and detailed characterization of 28 patients in a single-institution study. Jpn J Clin Oncol 2007;37:216–223.
   PubMed Web of Science ®Google Scholar
• Ueda T, Aozasa K, Ohsawa M, et al Malignant lymphomas of bone in Japan. Cancer 1989;64:2387–2392.
   PubMed Web of Science ®Google Scholar
• Copie-Bergman C, Niedobitek G, Mangham DC, et al Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation. J Pathol 1997;183:287–292.
   PubMed Web of Science ®Google Scholar
• McGrory JE, Pritchard DJ, Unni KK, et al Malignant lesions arising in chronic osteomyelitis. Clin Orthop Relat Res 1999:181–189.
   PubMed Web of Science ®Google Scholar
• Baar J, Burkes RL, Bell R, Blackstein ME, Fernandes B, Langer F. Primary non-Hodgkin's lymphoma of bone. A clinicopathologic study. Cancer 1994;73:1194–1199.
   PubMed Web of Science ®Google Scholar
• Fidias P, Spiro I, Sobczak ML, et al Long-term results of combined modality therapy in primary bone lymphomas. Int J Radiat Oncol Biol Phys 1999;45:1213–1218.
   PubMed Web of Science ®Google Scholar
• Gianelli U, Patriarca C, Moro A, et al Lymphomas of the bone: a pathological and clinical study of 54 cases. Int J Surg Pathol 2002;10:257–266.
   PubMed Web of Science ®Google Scholar
• Stein ME, Kuten A, Gez E, et al Primary lymphoma of bone – a retrospective study. Experience at the Northern Israel Oncology Center (1979–2000). Oncology 2003;64:322–327.
   PubMed Web of Science ®Google Scholar
• Isaacson PG, Norton AJ. Extranodal LymphomasEdinburgh, New York: Churchill Livingstone, 1994.
   Google Scholar
• Jones D, Kraus MD, Dorfman DM. Lymphoma presenting as a solitary bone lesion. Am J Clin Pathol 1999;111:171–178.
   PubMed Web of Science ®Google Scholar
• Stansfeld AG, Diebold J, Noel H, et al Updated Kiel classification for lymphomas. Lancet 1988;1:292–293.
   PubMed Web of Science ®Google Scholar
• Carbone PP, Kaplan HS, Musshoff K, et al Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971;31:1860–1861.
   PubMed Web of Science ®Google Scholar
• Shipp MA, Harrington DP, Anderson JR, et al A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987–994.
   PubMed Web of Science ®Google Scholar
• Oken MM, Creech RH, Tormey DC, et al Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649–655.
   PubMed Web of Science ®Google Scholar
• Coiffier B, Lepage E, Briere J, et al CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235–242.
   PubMed Web of Science ®Google Scholar
• Coiffier B, Lepage E, Herbrecht R. Mabthera (rituximab) plus CHOP is superior to CHOP alone in elderly patients with diffuse large b-cell lymphoma (DLBCL): interim results of a randomized GELA trial. Blood 2000;96:223a.
   Web of Science ®Google Scholar
• Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
   Web of Science ®Google Scholar
• DeAngelis LM, Yahalom J, Thaler HT, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992;10:635–643.
   PubMed Web of Science ®Google Scholar
• Dosoretz DE, Raymond AK, Murphy GF, et al Primary lymphoma of bone: the relationship of morphologic diversity to clinical behavior. Cancer 1982;50:1009–1014.
   PubMed Web of Science ®Google Scholar
• Bacci G, Ferraro A, Casadei R, et al Primary lymphoma of bone: long term results in patients treated with vincristine–adriamycin–cyclophosphamide and local radiation. J Chemother 1991;3:189–193.
   PubMed Web of Science ®Google Scholar
• Rathmell AJ, Gospodarowicz MK, Sutcliffe SB, et al Localised lymphoma of bone: prognostic factors and treatment recommendations. The Princess Margaret Hospital Lymphoma Group. Br J Cancer 1992;66:603–606.
   PubMed Web of Science ®Google Scholar
• Fairbanks RK, Bonner JA, Inwards CY, et al Treatment of stage IE primary lymphoma of bone. Int J Radiat Oncol Biol Phys 1994;28:363–372.
   PubMed Web of Science ®Google Scholar
• Bayrakci K, Yildiz Y, Saglik Y, et al Primary lymphoma of bones. Int Orthop 2001;25:123–126.
   PubMed Web of Science ®Google Scholar
• de Camargo OP, dos Santos Machado TM, Croci AT, et al Primary bone lymphoma in 24 patients treated between 1955 and 1999. Clin Orthop Relat Res 2002:271–280.
   PubMed Web of Science ®Google Scholar
• Marshall DT, Amdur RJ, Scarborough MT, et al Stage IE primary non-Hodgkin's lymphoma of bone. Clin Orthop Relat Res 2002:216–222.
   PubMed Web of Science ®Google Scholar
• de Leval L, Braaten KM, Ancukiewicz M, et al Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation. Am J Surg Pathol 2003;27:1269–1277.
   PubMed Web of Science ®Google Scholar
• Zinzani PL, Carrillo G, Ascani S, et al Primary bone lymphoma: experience with 52 patients. Haematologica 2003;88:280–285.
   PubMed Web of Science ®Google Scholar
• Barbieri E, Cammelli S, Mauro F, et al Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II. Int J Radiat Oncol Biol Phys 2004;59:760–764.
   PubMed Web of Science ®Google Scholar
• Beal K, Allen L, Yahalom J. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients. Cancer 2006;106:2652–2656.
   PubMed Web of Science ®Google Scholar
• Horsman JM, Thomas J, Hough R, et al Primary bone lymphoma: a retrospective analysis. Int J Oncol 2006;28:1571–1575.
   PubMed Web of Science ®Google Scholar
• Catlett JP, Williams SA, O'Connor SC, et al Primary lymphoma of bone: an institutional experience. Leuk Lymphoma 2008;49:2125–2132.
   PubMed Web of Science ®Google Scholar
• Mendenhall NP, Jones JJ, Kramer BS, et al The management of primary lymphoma of bone. Radiother Oncol J Eur Soc Ther Radiol Oncol 1987;9:137–145.
   PubMed Web of Science ®Google Scholar
• Brousse C, Baumelou E, Morel P. Primary lymphoma of bone: a prospective study of 28 cases. Joint Bone Spine 2000;67:446–451.
   PubMed Web of Science ®Google Scholar
• Shannon JA, Bell DR, Levi JA, et al Bone presentation of non-Hodgkin's lymphoma: experience at the Royal North Shore Hospital, Sydney; highlighting primary bone lymphoma. Aust N Z J Med 1994;24:701–704.
   PubMedGoogle Scholar
• Zucca E, Roggero E, Bertoni F, et al Primary extranodal non-Hodgkin's lymphomas. Part 2: head and neck, central nervous system and other less common sites. Ann Oncol 1999;10:1023–1033.
   PubMed Web of Science ®Google Scholar
• Miller TP, Dahlberg S, Cassady JR, et al Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998;339:21–26.
   PubMed Web of Science ®Google Scholar
• Horning SJ, Weller E, Kim K, et al Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol 2004;22:3032–3038.
   PubMed Web of Science ®Google Scholar
• Miller TP, LeBlanc M, Spier CM. CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin's lymphomas: uptodate of the Southwestern Oncology Group (SWOG) randomized trial. Blood 2001;98:724a.
   Google Scholar
• Bonnet C, Fillet G, Mounier N, et al CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2007;25:787–792.
   PubMed Web of Science ®Google Scholar
• Reyes F, Lepage E, Ganem G, et al ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med 2005;352:1197–1205.
   PubMed Web of Science ®Google Scholar
• Feugier P, Van Hoof A, Sebban C, et al Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2005;23:4117–4126.
   PubMed Web of Science ®Google Scholar
• Pfreundschuh M, Trumper L, Osterborg A, et al CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006;7:379–391.
   PubMed Web of Science ®Google Scholar
• Sehn LH, Donaldson J, Chhanabhai M, et al Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 2005;23:5027–5033.
   PubMed Web of Science ®Google Scholar